Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients S. Erb, R. Frei,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000–2012 M. Tvede,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

How to discriminate contamination from bloodstream infection due to coagulase- negative staphylococci: a prospective study with 654 patients L. Elzi,

J.-C. Lagier Clinical Microbiology and Infection

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics Y.H. van Beurden, S. Nezami,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance—a retrospective population based study.

R. Cantón Clinical Microbiology and Infection

A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J

New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to.

Dermatitis by Dermatophilus congolensis

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithm C. Beaulieu, L.-L.

Validation of a treatment algorithm for orthopaedic implant-related infections with device-retention—results from a prospective observational cohort study

H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi

How to discriminate contamination from bloodstream infection due to coagulase- negative staphylococci: a prospective study with 654 patients L. Elzi,

Comparing the economic and health benefits of different approaches to diagnosing Clostridium difficile infection Sarah M. Bartsch, Craig A. Umscheid,

Vector control: a cornerstone in the malaria elimination campaign

Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012– 2014: prospective, repeated cross-sectional study L. Furuya-Kanamori,

Comparison of respiratory virus shedding by conventional and molecular testing methods in patients with haematological malignancy L. Richardson, J. Brite,

F. Barbut, L. Surgers, C. Eckert, B. Visseaux, M. Cuingnet, C

Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients.

Laboratory diagnosis and biosafety issues of biological warfare agents

Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit E. Theocharidou, B. Agarwal, G. Jeffrey,

M.H. Wilcox Clinical Microbiology and Infection

S. Imbert, J.-Y. Brossas, M. Palous, I. Joly, I. Meyer, A. Fekkar

The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study E. Manea, J. Sojo-Dorado, R.E. Jipa, S.N.

L. Fenner, A. F. Widmer, A. Stranden, M. Conzelmann, A. Goorhuis, C

Mathematical modeling of Clostridium difficile infection

Metagenomics and probiotics

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection M.J.T.

Simplifying the WHO ‘how to hand rub’ technique: three steps are as effective as six— results from an experimental randomized crossover trial S. Tschudin-Sutter,

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples J. Stahlmann,

N. Jazmati, M. Hellmich, B. Ličanin, G. Plum, A.J. Kaasch

A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures A. Makristathis, S. Riss, A.M. Hirschl

How well does physician selection of microbiologic tests identify Clostridium difficile and other pathogens in paediatric diarrhoea? Insights using multiplex.

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Microbiologic factors affecting Clostridium difficile recurrence

C.P. Kelly Clinical Microbiology and Infection

Clostridium difficile toxin testing by National Health Service (NHS) acute Trusts in England: 2008–2013 S.M. Gerver, A.P. Johnson, R.J. Hope Clinical.

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe

Trends and changes in Clostridium difficile diagnostic policies and their impact on the proportion of positive samples: a national survey A. Adler, Y.

J.L. Balcázar Clinical Microbiology and Infection

Typing of Clostridium difficile

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection A. Russo, M. Falcone, M. Fantoni, R. Murri,

Presentation transcript:

Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients S. Erb, R. Frei, A.M. Strandén, M. Dangel, S. Tschudin-Sutter, A.F. Widmer Clinical Microbiology and Infection Volume 21, Issue 11, Pages 998.e9-998.e15 (November 2015) DOI: 10.1016/j.cmi.2015.07.016 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Enrollment and results of CDI patients with toxin EIA and TC. CDI, Clostridium difficile infection; EIA, enzyme immunoassay; ESCMID, European Society of Clinical Microbiology and Infectious Diseases; GDH, C. difficile glutamate dehydrogenase antigen (from 2008 onwards); nontoxigenic C. difficile: culture positive for C. difficile, but toxin EIA directly from stool and TC negative; TC, toxigenic culture. Clinical Microbiology and Infection 2015 21, 998.e9-998.e15DOI: (10.1016/j.cmi.2015.07.016) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions